Abstract:The last step in influenza virus replication involves the assembly of viral components on the infected cell's plasma membrane followed by budding of intact virus from the host cell surface. Because viral neuraminidase and hemagglutinin are both inserted into the host cell's membrane during this process, influenza virus-infected cells are distinguished from uninfected cells by the presence of viral neuraminidase and hemagglutinin on their cell surfaces. In an effort to exploit this difference in cell surface markers for development of diagnostic and therapeutic agents, we have modified an influenza neuraminidase inhibitor, zanamivir, for targeting of attached imaging and therapeutic agents selectively to influenza viruses and virus-infected cells. We have designed here a zanamivir-conjugated rhodamine dye that allows visual monitoring of binding, internalization, and intracellular trafficking of the fluorescence-labeled neuraminidase in virus-infected cells. We also synthesize a zanamivir-<sup>99m</sup>Tc radioimaging conjugate that permits whole body imaging of the virus's biodistribution and abundance in infected mice. Finally, we create both a zanamivir-targeted cytotoxic drug (i.e., zanamivir-tubulysin B) and a viral neuraminidase-targeted CAR T cell and demonstrate that they are both able to kill viral neuraminidase-expressing cells without damaging healthy cells. Taken together, these data suggest that the influenza virus neuraminidase inhibitor, zanamivir, can be exploited to improve the diagnosis, imaging, and treatment of influenza virus infections.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.bioconjchem.1c00255?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.bioconjchem.1c00255</a>.Experimental details, materials, and methods, including the spectra of the compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.bioconjchem.1c00255/suppl_file/bc1c00255_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Topology‐Matching Design of an Influenza‐Neutralizing Spiky Nanoparticle‐Based Inhibitor with a Dual Mode of Action

Heteromultivalent Topology-Matched Nanostructures As Potent and Broad-Spectrum Influenza A Virus Inhibitors.

Spiky Nanostructures with Geometry-matching Topography for Virus Inhibition

Spiky Nanostructures for Virus Inhibition and Infection Prevention

Identification of a Small-Molecule Inhibitor of Influenza Virus Via Disrupting the Subunits Interaction of the Viral Polymerase.

Residue-based Design of Small Molecule Inhibitor for H1N1, H5N1 and H7N1 Mutants

Influenza neuraminidase operates via a nucleophilic mechanism and can be targeted by covalent inhibitors

A Novel Small-Molecule Compound Disrupts Influenza A Virus PB2 Cap-Binding and Inhibits Viral Replication.

A Combined Computational and Experimental Approach

Identification of the Imidazo[1,2- a]pyrazine Derivative A4 as a Potential Influenza Virus Nucleoprotein Inhibitor

Biomimetic Nanoparticles As Universal Influenza Vaccine

Discovery and Characterization of a Novel Peptide Inhibitor Against Influenza Neuraminidase

Recent advances in the structure-based design of neuraminidase inhibitors as antiinfluenza agents.

Chemoreactive-Inspired Discovery of Influenza A Virus Dual Inhibitor to Block Hemagglutinin-Mediated Adsorption and Membrane Fusion.

Design of Neuraminidase-Targeted Imaging and Therapeutic Agents for the Diagnosis and Treatment of Influenza Virus Infections

Design, synthesis, and biological activity of a novel series of 2-ureidonicotinamide derivatives against influenza A virus

A pan-influenza antibody inhibiting neuraminidase via receptor mimicry

Design,Synthesis and Anti-influenza Activities of Novel Neuraminidase Inhibitors

Dual neutralization of influenza virus hemagglutinin and neuraminidase by a bispecific antibody leads to improved antiviral activity

Influenza Neuraminidase Characteristics and Potential as a Vaccine Target

Bifunctional Inhibitors of Influenza Virus Neuraminidase: Molecular Design of a Sulfonamide Linker